Hosted on MSN7mon
HUGE Stock Earnings: FSD Pharma Misses EPS for Q2 2024FSD Pharma (NASDAQ:HUGE) just reported results for the second quarter of 2024. FSD Pharma reported earnings per share of -8 cents. This was below the analyst estimate for EPS of -6 cents.
FSD Pharma Inc. (Nasdaq: HUGE) (CSE:HUGE) (FRA:0K9) (the “Company” or “FSD”) is pleased to announce the results of its annual general and special meeting of the shareholders held on May ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results